Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03004313 · ClinicalTrials.gov registry record · NA
Structural and Molecular Neuroplasticity in Migraine
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT03004313 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 32 participants.
The verdict
NCT03004313, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
The main purpose of this study is to integrate novel MRI techniques with positron emission tomography(PET) for the study of structural and molecular neuroplasticity in the brain of migraineurs, and its clinical association with changes in pain perception and modulation (e.g. allodynia). We will attempt to acquire images of the brain that may, in the future, assist doctors in better understanding how pain is felt and regulated in migraine sufferers.
Interventions
- PROCEDURE MRI scan
- PROCEDURE Pet Scan
- PROCEDURE Quantitative Sensory Testing (QST)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2011-01 |
| Est. Completion | 2014-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03004313
The ClinicalTrials.gov registry entry for NCT03004313 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which MRI scan is the first listed.
NCT03004313 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03004313 about?
NCT03004313 is a clinical study titled "Structural and Molecular Neuroplasticity in Migraine". The main purpose of this study is to integrate novel MRI techniques with positron emission tomography(PET) for the study of structural and molecular neuroplasticity in the brain of migraineurs, and its clinical association with changes in pain perception and modulation (e.g. allodynia). We will atte...
What is the current status of trial NCT03004313?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2011-01. Estimated completion is 2014-10.
What interventions are being tested in trial NCT03004313?
The interventions under investigation include: MRI scan (PROCEDURE), Pet Scan (PROCEDURE), Quantitative Sensory Testing (QST) (PROCEDURE).
Who is sponsoring clinical trial NCT03004313?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.